pembrolizumab,gemcitabine,cisplatin,durvalumab
astrazeneca,merck
['key,note,966', 'topaz 1']
intresting slide of comparison between topaz 1 and keynote 966. #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists